Calculated based on the number of publications stored in Pure and citations from PlumX
1991 …2025

Research activity per year

Personal profile

About

Benedict C. Albensi, Ph.D., BCMAS, CRQM is a Professor and Chair of the Department of Pharmaceutical Sciences. He is best known for his work with factors involved in ageing, cognition, and Alzheimer's disease (AD), such as nuclear factor kappa B (NF-kB), a mediator of inflammation but also a required molecule for memory.

He obtained his Ph.D. in Neuroscience from the University of Utah's Medical School in 1995. Subsequently, he was awarded a Postdoctoral Fellowship at Georgetown University in Washington, DC, working with Drs. Faden and Pekar, where he developed MRI methods for investigating head trauma and cognition. He then went on to work as a Postdoctoral Scholar with Dr. Mark Mattson, an internationally recognized leader in neurodegenerative research, at the Sanders-Brown Center on Aging - University of Kentucky where he was the first to show NF-kB is required for hippocampal synaptic plasticity in mammals. Other appointments have included the Cleveland Clinic, NPS Pharmaceuticals, Pfizer, Case Western Reserve University, St. Boniface Hospital Research Ctr., and the University of Manitoba.

Over the last few years, his work has largely focused on mitochondrial dysfunction in AD. Recently, the Albensi lab has shown very early deficits and sex-based differences in mitochondrial function before the appearance of plaques and tangles, the classic hallmarks of AD. He has been ranked in the top 1% worldwide by Expertscape.com for his number of publications from 2010-2020 in 7 areas including Alzheimer Disease (0.48%), neurocognitive disorders (0.76%), tauopathies (0.98%), dementia (0.85%), NF-kappa B (0.42%), memory (68%) & energy metabolism (0.68%).

Student Research Opportunities - The Albensi lab focuses on understanding basic mechanisms of biological memory and also investigating causes of memory impairments, such as what is seen in Alzheimer's disease. Volunteers are usually welcomed if space permits. Dependent on funding, additional opportunities exist for lab technicians, PharmD students, MS or PhD students, postdoctoral fellows, and/or research associates.

Research Interests - Memory; Alzheimer's disease; Inflammation; Mitochondria; NF-kB Signaling ; Clinical trials and animal models

Related documents

Education/Academic qualification

Postdoctoral Scholar, University of Kentucky

19971999

Postdoctoral Fellow, Georgetown University

19961997

Ph.D. Neuroscience

19911995

Certificate in Management, University of Utah

1994

M.A. Biology, Sonoma State University

… → 1992

B.S. General Science, University of Oregon

… → 1982

External positions

Editor-in-Chief, Springer-Nature Publication

2020 → …

Full Professor, University of Manitoba

20162025

Adjunct Professor, University of Manitoba

20102013

Associate Professor - Tenured, University of Manitoba

20092016

Associate Professor , University of Manitoba

20092016

Scientist, University of Manitoba

20062021

Research Affiliate, University of Manitoba

20062021

Principal Investigator, St. Boniface Hospital Albrechtsen Research Centre

20052025

Assistant Professor, University of Manitoba

20052009

Adjunct Assistant Professor, Case Western Reserve University

20032004

Project Staff (equivalent to Research Assistant Professor), The Cleveland Clinic Foundation

20012004

Research Contractor, Pfizer Global Research & Development, Inc.

19992001

Research Associate, University of Utah

19871991

Analytical Chemist, ETTC (Environmental Chemistry & Toxicology)

19861987

Research Interests

  • memory
  • Alzheimer's disease
  • NF-kB signaling
  • mitochondria
  • inflammation
  • intelligence

Disciplines

  • Pharmacy and Pharmaceutical Sciences
  • Neuroscience and Neurobiology

Fingerprint

Dive into the research topics where Benedict Albensi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or